Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5582)
All Articles published online
|
Publishing Process of This Article
|
Sep 7, 2017 (publication date) through Jun 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kazakos EI, Dorrell N, Polyzos SA, Deretzi G, Kountouras J. Comment on “Effect of biofilm formation by clinical isolates of Helicobacter pylori on the efflux-mediated resistance to commonly used antibiotics”. World J Gastroenterol 2017; 23(33): 6194-6196 [PMID: 28970736 DOI: 10.3748/wjg.v23.i33.6194] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i33/6194.htm |
| Number | Citing Articles |
| 1 |
Jannis Kountouras, Michael Doulberis, Apostolis Papaefthymiou, Stergios A. Polyzos, Christos Zavos, Evangelos Kazakos, Stergios Arapoglou, Foteini Kyrailidi, Maria C. Mouratidou, Marina Boziki, Elisabeth Vardaka. Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration. Medicina 2023; 59(3): 504 doi: 10.3390/medicina59030504
|
| 2 |
Jannis Kountouras. Concentrating on the Long Topic of Empirical or Not Conventional Helicobacter pylori Eradication Regimens. Clinical Gastroenterology and Hepatology 2023; 21(9): 2433 doi: 10.1016/j.cgh.2022.10.027
|
| 3 |
Jannis Kountouras, Evangelos Kazakos, Stergios A. Polyzos, Dimitrios Chatzopoulos, Maria Tzitiridou‐Chatzopoulou, Michael Doulberis, Apostolis Papaefthymiou, Elisabeth Vardaka. GM‐CSF as a potential candidate of a vaccine‐induced reduction ofHelicobacter pyloriinfection. Helicobacter 2022; 27(3) doi: 10.1111/hel.12884
|
| 4 |
Jannis Kountouras. Thinking of the Long Puzzling Issue of Several Suboptimal Treatments of Helicobacter pylori Infection. American Journal of Gastroenterology 2023; 118(11): 2093 doi: 10.14309/ajg.0000000000002305
|
| 5 |
Jannis Kountouras, Michael Doulberis, Stergios A. Polyzos, Evangelos Kazakos, Elisabeth Vardaka, Maria Tzitiridou‐Chatzopoulou, Dimitrios Chatzopoulos, Christos Liatsos, Antony Kyriakopoulos, Apostolis Papaefthymiou. Emerging parameters relevant to the management of antimicrobial‐resistant Helicobacter pylori infection. Internal Medicine Journal 2022; 52(9): 1654 doi: 10.1111/imj.15872
|
| 6 |
Lyudmila Boyanova, Petyo Hadzhiyski, Nayden Kandilarov, Rumyana Markovska, Ivan Mitov. Multidrug resistance inHelicobacter pylori: current state and future directions. Expert Review of Clinical Pharmacology 2019; 12(9): 909 doi: 10.1080/17512433.2019.1654858
|
| 7 |
Mulan Li, Ying Liu, Youhuan Gong, Xiaojie Yan, Le Wang, Wenfu Zheng, Hao Ai, Yuliang Zhao. Recent advances in nanoantibiotics against multidrug-resistant bacteria. Nanoscale Advances 2023; 5(23): 6278 doi: 10.1039/D3NA00530E
|
| 8 |
Olga P. Nyssen, Leticia Moreira, Natalia García-Morales, Anna Cano-Català, Ignasi Puig, Francis Mégraud, Colm O’Morain, Javier P. Gisbert. European Registry on Helicobacter pylori Management (Hp-EuReg): Most relevant results for clinical practice. Frontiers in Gastroenterology 2022; 1 doi: 10.3389/fgstr.2022.965982
|
| 9 |
Christos Liatsos, Apostolis Papaefthymiou, Nikolaos Kyriakos, Michail Galanopoulos, Michael Doulberis, Marios Giakoumis, Evangelia Petridou, Christos Mavrogiannis, Theodore Rokkas, Jannis Kountouras. <i>Helicobacter pylori</i>, gastric microbiota and gastric cancer relationship: Unrolling the tangle. World Journal of Gastrointestinal Oncology 2022; 14(5): 959-972 doi: 10.4251/wjgo.v14.i5.959
|
| 10 |
Paweł Krzyżek, Rossella Grande, Paweł Migdał, Emil Paluch, Grażyna Gościniak. Biofilm Formation as a Complex Result of Virulence and Adaptive Responses of Helicobacter pylori. Pathogens 2020; 9(12): 1062 doi: 10.3390/pathogens9121062
|
| 11 |
Raluca Ioana Dascălu, Alexandra Bolocan, Dan Nicolae Păduaru, Alexandru Constantinescu, Magda Mihaela Mitache, Anca Daniela Stoica, Octavian Andronic. Multidrug resistance in Helicobacter pylori infection. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1128497
|
| 12 |
Michael Doulberis, Jannis Kountouras, Gerhard Rogler. Reconsidering the “protective” hypothesis of Helicobacter pylori infection in eosinophilic esophagitis. Annals of the New York Academy of Sciences 2020; 1481(1): 59 doi: 10.1111/nyas.14449
|
| 13 |
Theodore Rokkas, Konstantinos Ekmektzoglou.
Advances in the pharmacological and regulatory management of multidrug resistant
Helicobacter pylori
. Expert Review of Clinical Pharmacology 2023; 16(12): 1229 doi: 10.1080/17512433.2023.2282061
|
| 14 |
Michael Doulberis, Georgios Kotronis, Robert Thomann, Stergios A. Polyzos, Marina Boziki, Dimitra Gialamprinou, Georgia Deretzi, Panagiotis Katsinelos, Jannis Kountouras. Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?. Helicobacter 2018; 23(1) doi: 10.1111/hel.12454
|
| 15 |
Jannis Kountouras. Considering the Long-Conflicting Topic of Empirical or Nonconventional Helicobacter pylori Eradication Regimens. Gut and Liver 2023; 17(4): 659 doi: 10.5009/gnl220450
|